Additional file 1: of The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial

Tripolt, Norbert; Aberer, Felix; Riedl, Regina; Hutz, Barbara; Url, Jasmin; Dimsity, Gudrun; Meinitzer, Andreas; Stojakovic, Tatjana; Hรถdl, Ronald; Brodmann, Marianne; Hafner, Franz; Sourij, Harald

doi:10.6084/m9.figshare.c.3599543_D1.v1

13063_2016_1627_MOESM1_ESM.pdf (74.99 kB)

Additional file 1: of The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial

journal contribution

posted on 2016-10-13, 05:00 authored by Norbert Tripolt, Felix Aberer, Regina Riedl, Barbara Hutz, Jasmin Url, Gudrun Dimsity, Andreas Meinitzer, Tatjana Stojakovic, Ronald Hรถdl, Marianne Brodmann, Franz Hafner, Harald Sourij

SPIRIT checklist. (PDF 74 kb)

Funding

Boehringer Ingelheim

History

Usage metrics

Keywords

Linagliptin DPP-4 inhibitor Endothelial function Global arginine bioavailability ratio Coronary artery disease Type 2 diabetes mellitus

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial

Funding

Boehringer Ingelheim

History

Usage metrics

Categories

Keywords

Licence

Exports